Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes
Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes
复制标题
DOI:
10.1073/pnas.1001360107
复制
发表时间:
2010-03-23
影响因子:
11.1
通讯作者:
Hofmann, Franz
中科院分区:
文献类型:
--
作者:
Lukowski, Robert;Rybalkin, Sergei D.;Hofmann, Franz
It has been suggested that cGMP kinase I (cGKI) dampens cardiac hypertrophy. We have compared the effect of isoproterenol (ISO) and transverse aortic constriction (TAC) on hypertrophy in WT [ control (CTR)] mice, total cGKI-KO mice, and cGKI beta rescue mice (beta RM) lacking cGKI specifically in cardiomyocytes (CMs). Infusion of ISO did not change the expression of cGKI in the hearts of CTR mice or beta RM but raised the heart weight by similar to 20% in both. An identical hypertrophic growth response was measured in CMs from CTR mice and beta RM and in isolated adult CMs cultured with or without 1 mu M ISO. In both genotypes, ISO infusion induced similar changes in the expression of hypertrophy-associated cardiac genes and significant elevation of serum atrial natriuretic peptide and total cardiac cGMP. No differences in cardiac hypertrophy were obtained by 7-day ISO infusion in 4- to 6-week-old conventional cGKI-KO and CTR mice. Furthermore, TAC-induced hypertrophy of CTR mice and beta RM was not different and did not result in changes of the cGMP-hydrolyzing phosphodiesterase activities in hypertropic hearts or CMs. These results strongly suggest that cardiac myocyte cGKI does not affect the development of heart hypertrophy induced by pressure overload or chronic ISO infusion.